<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>After organ transplantation, life-long immunosuppression is mandatory to prevent rejection </plain></SENT>
<SENT sid="1" pm="."><plain>This is not the case after allogeneic bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="2" pm="."><plain>The mechanisms of tolerance are little understood and there is little data about the required duration of immunosuppression </plain></SENT>
<SENT sid="3" pm="."><plain>In a retrospective study we analyzed the use of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A (CyA) treatment in <z:hpo ids='HP_0000001'>all</z:hpo> BMT patients who where transplanted in Basel from 1979 to 1991 </plain></SENT>
<SENT sid="4" pm="."><plain>243 patients with a median age of 26 (2-49) years received CyA to prevent <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host-disease</z:e> (GvHD) and rejection </plain></SENT>
<SENT sid="5" pm="."><plain>206 patients had <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 26 severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and 10 a <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were treated according to a common CyA regimen with initial parenteral administration followed by oral treatment for a year; after 1988 treatment duration was reduced to 6 months </plain></SENT>
<SENT sid="7" pm="."><plain>Drug dosage was adjusted according to clinical symptoms, plasma levels and toxicity </plain></SENT>
<SENT sid="8" pm="."><plain>At relapse of the original disease CyA was always withdrawn </plain></SENT>
<SENT sid="9" pm="."><plain>Three months after BMT 96% were still on CyA </plain></SENT>
<SENT sid="10" pm="."><plain>After 6 months 79%, after 1 year 61%, after 2 years 29%, after 3 years 18%, after 4 years 15%, after 5 years 8% and after 8 years 2% of patients were still taking CyA </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 20 patients who are still alive 10 years after BMT are off CyA </plain></SENT>
<SENT sid="12" pm="."><plain>CyA was administered parenterally for a median of 31 (5-147) days </plain></SENT>
<SENT sid="13" pm="."><plain>Oral treatment started at day 25 (4-28) </plain></SENT>
<SENT sid="14" pm="."><plain>The oral dose was reduced 5 (1-20) times, increased once (1-75) and finally discontinued after a median time lapse of 1 year (14d-8y).(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>